OR WAIT null SECS
© 2024 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Catherine Shaffer is a contributing writer to BioPharm International, email@example.com.
May 15, 2017
A multi-pronged approach to raw materials testing can help mitigate the risk of future contamination events.
Manufacturing for originator molecules is restricted by regulations, but drug makers can exploit newer technologies for the manufacture of biosimilars.